Notice Number: NOT-DA-08-016
Key Dates
Release Date: April 30, 2008
Issued by
National Institute on Drug Abuse (NIDA), (http://www.nida.nih.gov)
The purpose of this notice is to clarify eligibility requirements of the Early Career Award in Chemistry of Drug Abuse and Addiction (ECHEM) (http://grants.nih.gov/grants/guide/pa-files/PAS-07-327.html) award for potential applicants. Investigators who fulfill the NIH definition of New Investigator are encouraged to apply.
In general, a Program Director/Principal Investigator (PD/PI) is considered a New Investigator if he/she has not previously competed successfully as PD/PI for a significant NIH independent research award. Specifically, a PD/PI is identified as a New Investigator if he/she has not previously competed successfully for an NIH-supported research project other than the following small or early stage research awards:
- Pathway to Independence Award-Research Phase (R00)
- Small Grant (R03)
- Academic Research Enhancement Award (R15)
- Exploratory/Developmental Grant (R21)
- Clinical Trial Planning Grant (R34)
- Dissertation Award (R36)
- Small Business Technology Transfer Grant-Phase I (R41)
- Small Business Innovation Research Grant-Phase I (R43)
- Shannon Award (R55)
- NIH High Priority, Short-Term Project Award (R56)
Training-Related and Mentored Career Awards
- Fellowships (F05, F30, F31, F32, F34, F37, F38)
- Mentored-career awards (K01, K08, K22, K23, K25, K99-R00)
Instrumentation, Construction, Education, or Meeting Awards
- G07, G08, G11, G13, G20
- S10, S15
- X01, X02
- R25
- C06, UC6
- R13, U13
Inquiries
Rao Rapaka, Ph.D.
Chief
Chemistry and Physiological Systems Research Branch
Division of Basic Neuroscience and Behavioral Research
National Institute on Drug Abuse
6001 Executive Blvd.
Bethesda, MD 20892
Phone: 301-435-1304
FAX: 301-594-6043
E-mail. rrapaka@nida.nih.gov
and Human Services (HHS)
